4th Indo-American Health Dialogue 2021 concludes – India Education | Latest Education News | Global education news


New Delhi: Mansukh Mandaviya, Union Minister for Health and Family Welfare spoke today at the closing session of the 4th Indo-American Dialogue on Health hosted by India.

The two-day dialogue served as a platform to deliberate on the multiple ongoing collaborations in the health sector between the two countries. Issues related to areas of concern regarding strengthening of epidemiological research and surveillance, vaccine development, One Health, zoonotic and vector-borne diseases, health systems and health policies, etc. were discussed during the two-day dialogue.

New Delhi: two memorandums of understanding were also signed today during the closing session. A Memorandum of Understanding has been signed between the Department of Health and Family Welfare of the Republic of India and the Department of Health and Human Services of the United States regarding cooperation in the field of health and biomedical sciences. Another Memorandum of Understanding has been signed between the Indian Council for Medical Research (ICMR) and the National Institute of Allergy and Infectious Diseases (NIAID) for cooperation on the International Center for Research Excellence (ICER).

Marking the end of the two-day dialogue, Union Health Minister Shri Mansukh Mandaviya delivered a special address on the closing day of the 4th Indo-American Health Dialogue.

His speech is as follows:

I am delighted to be here with you to attend the closing session of the Fourth Health Dialogue between India and the United States.

For India, we value our engagement with the United States on various fronts and we have come a long way in the past to continually nurture this relationship. With the United States being the oldest modern democratic country and India being the largest democratic country in the modern world, constructive and positive cooperation between the two countries can lead to,

Peace,
harmony and
Growth, not only for both sides, but for the world in general.
I remember the year 2000, when during his trip to the United States, our then Honorable Prime Minister, the late Shri Atal Behari Vajpayee ji, described India and the United States as “natural allies. “. And today, the Indo-American Health Dialogue’s emphasis on fostering cooperation and collaboration, in medicine and health to help – health for all, is truly commendable.

The recently concluded visit of our Hon’ble Prime Minister to the United States, for deliberations, a comprehensive global strategic partnership and an exchange of views on regional and global issues of mutual interest, particularly in the field of science and technology, is another important step towards strengthening our bilateral relations.

And, I am sure, the outcome of this visit will also benefit our ongoing collaborations in the healthcare sector. India and the United States are also actively engaged with other Indo-Pacific countries on,

COVID response,
Development of vaccines,
Sharing of good practices,
Supply chain management and,
Boost savings.
In addition, the participation of the Honorable Prime Minister Shri Narendra Modi ji, in the first in-person Quad Leaders Summit on September 24, to identify new areas of cooperation, will also consolidate this partnership and strengthen the positive and constructive relationship of areas of cooperation. which will benefit the entire Indo-Pacific region.

The continued collaboration between two nations in various fields such as environmental and occupational health,

Prevention and control of injuries,
Climate change and human health,
Antimicrobial resistance,
HIV / AIDS, Engagement with USFDA to understand the PREDICT model which is a risk-based management tool for,
import control,
Funding for clinical research fellowships for early and mid-career scientists in India and the United States will certainly help build a strong and sustainable healthcare system with qualified healthcare professionals.
We all know India and the United States are global partners, and we also need to work together to reform the global health architecture, the flaws of which have become widely visible during the current pandemic.

Equally important areas where India and the United States can work are health emergency management, support for digital health and innovation, mental health interventions, research associated with production linked to diagnostics, therapeutics and vaccines, given India’s offer of its low-cost research network and enormous production capacities. This has implications for access and affordability of medicines not only for the United States and India, but also for the entire world.

It should be mentioned that Indian generic drugs have helped to lower the cost of treating various diseases around the world.

India supplies almost all high quality generic drugs in the developing world. We are also the largest manufacturer of anti-tuberculosis drugs. By leveraging this capability, we can deliver high-quality, affordable medicines to patients around the world.

I also note with satisfaction the increased convergence between regulators in the two countries and look forward to further tangible results and combined work on this issue in global forums as well.

At the end of the health dialogue, I hope both sides resume the rich learning experience and reaffirm their commitment to bilateral cooperation.

I’m sure you all had a comfortable stay in India and also got to take the time to see India’s rich cultural heritage. I wish, however, that you could have stayed longer or rather, I am looking forward to another visit to India soon.

Let us continue to work together, in our common interest and in the interest of the world at large.

The United States delegation for the dialogue was led by Ms. Patricia A Lacina, Chargé d’affaires, United States Embassy. Ms. Loyce Pace, Director, Office of Global Affairs, US Department of Health and Human Services (HHS). Ms. Michelle McConnell, Director, Asia and the Pacific, Office of Global Affairs, US Department (HHS), Dr. Preetha Rajaraman, Health Officer, HHS, Ms. Sangita Patel, Director, USAID / HO, Ms. Nandita Chopra, NIAID The HHS Representative / NIH and Dr Melissa Nyendak, Director of the Global HIV and Tuberculosis Division, HHS / CDC were present at the meeting.

Shri Rajesh Bhushan, Trade Union Secretary for Health, Dr Balram Bharagava, Secy (DHR) and DG (ICMR), Sh. Alok Saxena, AS & DG, (NACO), Sh. Lav Agarwal, JS (PH), Sh. Vishal Chauhan, JS (Politics and MNT), Dr MK Bhandari, JS (Reg and ME), Sh. P Ashok Babu, JS (RCH); Dr VG Somani, DCGI, and other senior ministry officials represented India at the event.

About Warren Dockery

Check Also

UNHCR warns of rising tensions between Lebanese nationals and Syrian refugees

BEIRUT: In recent weeks in Lebanon, there has been a series of violent attacks and …

Leave a Reply

Your email address will not be published.